Home Reimbursed medicines Dasatinib
Dasatinib — maximum prices and reimbursement
The CANAMED catalogue contains 113 medicines with the active substance Dasatinib, from 9 manufacturers. Below you can see each entry with the brand name, the manufacturer, the maximum retail price, the reimbursement percentage and the prescription status — plus live pharmacy prices, where we track them.
113
CANAMED entries
9
Manufacturers
4167.93–18736.42
Maximum price (RON)
38
With a reimbursement percentage
In short: for the active substance Dasatinib there are 113 authorised medicines in the CANAMED catalogue, with maximum retail prices between 4167.93 and 18736.42 RON, from 9 manufacturers. For 38 of them the catalogue also records the reimbursement percentage. The maximum price is the legal cap — pharmacies may sell below it, so it is worth comparing the real price before you go. Latest import: 2026-11-03.
Data verified on from public sources (OpenStreetMap, chain websites, ANM/MS) — updated daily.
CANAMED catalogue
All medicines with Dasatinib
Maximum retail price = the legal selling cap. Sorted by price, lowest first.
| Brand name | Manufacturer | Maximum price | Reimbursement | Prescription |
|---|---|---|---|---|
| DASATINIB STADA 100 mg | REMEDICA LIMITED - CIPRU | 4167.93 RON | 100% · C2 (national programmes) CNAS pays ~4167.93 RON; you ~0.00 RON* |
PR |
| DASATINIB STADA 50 mg | REMEDICA LIMITED - CIPRU | 4198.86 RON | 100% · C2 (national programmes) CNAS pays ~4198.86 RON; you ~0.00 RON* |
PR |
| DASATINIB SUN 20 mg | SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. - TARILE DE JOS | 4254.73 RON | 100% · C2 (national programmes) CNAS pays ~4254.73 RON; you ~0.00 RON* |
PR |
| NODRIGA 20 mg | ALKALOID-INT D.O.O. - SLOVENIA | 4254.73 RON | 100% · C2 (national programmes) CNAS pays ~4254.73 RON; you ~0.00 RON* |
PR |
| DASATINIB MSN 100 mg | PHARMACARE PREMIUM LTD. - MALTA | 4449.61 RON | 100% · C2 (national programmes) CNAS pays ~4449.61 RON; you ~0.00 RON* |
PR |
| DASATINIB MSN 50 mg | PHARMACARE PREMIUM LTD. - MALTA | 4449.61 RON | 100% · C2 (national programmes) CNAS pays ~4449.61 RON; you ~0.00 RON* |
PR |
| DASATINIB ZENTIVA 100 mg | SYNTHON HISPANIA, S.L. - SPANIA | 4449.61 RON | 100% · C2 (national programmes) CNAS pays ~4449.61 RON; you ~0.00 RON* |
PR |
| DASATINIB ZENTIVA 100 mg | SYNTHON HISPANIA, S.L. - SPANIA | 4449.61 RON | 100% · C2 (national programmes) CNAS pays ~4449.61 RON; you ~0.00 RON* |
PR |
| DASATINIB ZENTIVA 100 mg | SYNTHON HISPANIA, S.L. - SPANIA | 4449.61 RON | 100% · C2 (national programmes) CNAS pays ~4449.61 RON; you ~0.00 RON* |
PR |
| DASATINIB ZENTIVA 50 mg | SYNTHON HISPANIA, S.L. - SPANIA | 4449.61 RON | 100% · C2 (national programmes) CNAS pays ~4449.61 RON; you ~0.00 RON* |
PR |
| DASATINIB ZENTIVA 50 mg | SYNTHON HISPANIA, S.L. - SPANIA | 4449.61 RON | 100% · C2 (national programmes) CNAS pays ~4449.61 RON; you ~0.00 RON* |
PR |
| DASATINIB ZENTIVA 50 mg | SYNTHON HISPANIA, S.L. - SPANIA | 4449.61 RON | 100% · C2 (national programmes) CNAS pays ~4449.61 RON; you ~0.00 RON* |
PR |
| NODRIGA 100 mg | ALKALOID-INT D.O.O. - SLOVENIA | 4471.17 RON | 100% · C2 (national programmes) CNAS pays ~4471.17 RON; you ~0.00 RON* |
PR |
| DASATINIB MSN 70 mg | PHARMACARE PREMIUM LTD. - MALTA | 4618.60 RON | 100% · C2 (national programmes) CNAS pays ~4618.60 RON; you ~0.00 RON* |
PR |
| DASATINIB ZENTIVA 70 mg | SYNTHON HISPANIA, S.L. - SPANIA | 4618.60 RON | 100% · C2 (national programmes) CNAS pays ~4618.60 RON; you ~0.00 RON* |
PR |
| DASATINIB ZENTIVA 70 mg | SYNTHON HISPANIA, S.L. - SPANIA | 4618.60 RON | 100% · C2 (national programmes) CNAS pays ~4618.60 RON; you ~0.00 RON* |
PR |
| DASATINIB ZENTIVA 70 mg | SYNTHON HISPANIA, S.L. - SPANIA | 4618.60 RON | 100% · C2 (national programmes) CNAS pays ~4618.60 RON; you ~0.00 RON* |
PR |
| NODRIGA 50 mg | ALKALOID-INT D.O.O. - SLOVENIA | 4658.67 RON | 100% · C2 (national programmes) CNAS pays ~4658.67 RON; you ~0.00 RON* |
PR |
| NODRIGA 70 mg | ALKALOID-INT D.O.O. - SLOVENIA | 4658.67 RON | 100% · C2 (national programmes) CNAS pays ~4658.67 RON; you ~0.00 RON* |
PR |
| DASATINIB TEVA 20 mg | MERCKLE GMBH - GERMANIA | 4807.38 RON | 100% · C2 (national programmes) CNAS pays ~4807.38 RON; you ~0.00 RON* |
PR |
| DASATINIB KRKA 100 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | 4857.23 RON | 100% · C2 (national programmes) CNAS pays ~4857.23 RON; you ~0.00 RON* |
PR |
| DASATINIB KRKA 50 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | 4857.23 RON | 100% · C2 (national programmes) CNAS pays ~4857.23 RON; you ~0.00 RON* |
PR |
| DASATINIB KRKA 70 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | 4857.23 RON | 100% · C2 (national programmes) CNAS pays ~4857.23 RON; you ~0.00 RON* |
PR |
| DASATINIB TEVA 100 mg | MERCKLE GMBH - GERMANIA | 4872.04 RON | 100% · C2 (national programmes) CNAS pays ~4872.04 RON; you ~0.00 RON* |
PR |
| DASATINIB TEVA 50 mg | MERCKLE GMBH - GERMANIA | 4872.04 RON | 100% · C2 (national programmes) CNAS pays ~4872.04 RON; you ~0.00 RON* |
PR |
| DASATINIB TEVA 70 mg | MERCKLE GMBH - GERMANIA | 4872.04 RON | 100% · C2 (national programmes) CNAS pays ~4872.04 RON; you ~0.00 RON* |
PR |
| DASATINIB SUN 100 mg | SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. - TARILE DE JOS | 4937.66 RON | 100% · C2 (national programmes) CNAS pays ~4937.66 RON; you ~0.00 RON* |
PR |
| DASATINIB SUN 50 mg | SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. - TARILE DE JOS | 4937.66 RON | 100% · C2 (national programmes) CNAS pays ~4937.66 RON; you ~0.00 RON* |
PR |
| DASATINIB SUN 70 mg | SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. - TARILE DE JOS | 4937.66 RON | 100% · C2 (national programmes) CNAS pays ~4937.66 RON; you ~0.00 RON* |
PR |
| DASATINIB SANDOZ 100 mg | REMEDICA LTD. - CIPRU | 4953.57 RON | 100% · C2 (national programmes) CNAS pays ~4953.57 RON; you ~0.00 RON* |
PRF |
| DASATINIB ZENTIVA 20 mg | SYNTHON HISPANIA, S.L. - SPANIA | 5018.24 RON | 100% · C2 (national programmes) CNAS pays ~5018.24 RON; you ~0.00 RON* |
PR |
| DASATINIB ZENTIVA 20 mg | SYNTHON HISPANIA, S.L. - SPANIA | 5018.24 RON | 100% · C2 (national programmes) CNAS pays ~5018.24 RON; you ~0.00 RON* |
PR |
| DASATINIB ZENTIVA 20 mg | SYNTHON HISPANIA, S.L. - SPANIA | 5018.24 RON | 100% · C2 (national programmes) CNAS pays ~5018.24 RON; you ~0.00 RON* |
PR |
| DASATINIB SANDOZ 70 mg | REMEDICA LTD. - CIPRU | 7074.04 RON | 100% · C2 (national programmes) CNAS pays ~5542.32 RON; you ~1531.72 RON* |
PRF |
| DASATINIB SANDOZ 50 mg | REMEDICA LTD. - CIPRU | 7557.07 RON | 100% · C2 (national programmes) CNAS pays ~5038.63 RON; you ~2518.44 RON* |
PRF |
| DASATINIB ACCORD HEALTHCARE 100 mg | ACCORD HEALTHCARE POLSKA SP. Z O.O. - POLONIA | 7954.06 RON | 100% · C2 (national programmes) CNAS pays ~5001.52 RON; you ~2952.54 RON* |
PR |
| DASATINIB ACCORD HEALTHCARE 50 mg | ACCORD HEALTHCARE POLSKA SP. Z O.O. - POLONIA | 14594.85 RON | 100% · C2 (national programmes) CNAS pays ~5038.63 RON; you ~9556.22 RON* |
PR |
| DASATINIB ACCORD HEALTHCARE 70 mg | ACCORD HEALTHCARE POLSKA SP. Z O.O. - POLONIA | 18736.42 RON | 100% · C2 (national programmes) CNAS pays ~5542.32 RON; you ~13194.10 RON* |
PR |
| DASATINIB KRKA 100 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| DASATINIB KRKA 140 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| DASATINIB KRKA 140 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| DASATINIB KRKA 20 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| DASATINIB KRKA 20 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| DASATINIB KRKA 50 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| DASATINIB KRKA 70 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| DASATINIB KRKA 80 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| DASATINIB KRKA 80 mg | KRKA, D.D., NOVO MESTO - SLOVENIA | — | not reimbursed | PR |
| DASATINIB MSN 100 mg | PHARMACARE PREMIUM LTD. - MALTA | — | not reimbursed | PR |
| DASATINIB MSN 100 mg | PHARMACARE PREMIUM LTD. - MALTA | — | not reimbursed | PR |
| DASATINIB MSN 140 mg | PHARMACARE PREMIUM LTD. - MALTA | — | not reimbursed | PR |
| DASATINIB MSN 140 mg | PHARMACARE PREMIUM LTD. - MALTA | — | not reimbursed | PR |
| DASATINIB MSN 140 mg | PHARMACARE PREMIUM LTD. - MALTA | — | not reimbursed | PR |
| DASATINIB MSN 20 mg | PHARMACARE PREMIUM LTD. - MALTA | — | not reimbursed | PR |
| DASATINIB MSN 20 mg | PHARMACARE PREMIUM LTD. - MALTA | — | not reimbursed | PR |
| DASATINIB MSN 20 mg | PHARMACARE PREMIUM LTD. - MALTA | — | not reimbursed | PR |
| DASATINIB MSN 20 mg | PHARMACARE PREMIUM LTD. - MALTA | — | not reimbursed | PR |
| DASATINIB MSN 50 mg | PHARMACARE PREMIUM LTD. - MALTA | — | not reimbursed | PR |
| DASATINIB MSN 50 mg | PHARMACARE PREMIUM LTD. - MALTA | — | not reimbursed | PR |
| DASATINIB MSN 50 mg | PHARMACARE PREMIUM LTD. - MALTA | — | not reimbursed | PR |
| DASATINIB MSN 70 mg | PHARMACARE PREMIUM LTD. - MALTA | — | not reimbursed | PR |
| DASATINIB MSN 70 mg | PHARMACARE PREMIUM LTD. - MALTA | — | not reimbursed | PR |
| DASATINIB MSN 70 mg | PHARMACARE PREMIUM LTD. - MALTA | — | not reimbursed | PR |
| DASATINIB MSN 80 mg | PHARMACARE PREMIUM LTD. - MALTA | — | not reimbursed | PR |
| DASATINIB MSN 80 mg | PHARMACARE PREMIUM LTD. - MALTA | — | not reimbursed | PR |
| DASATINIB MSN 80 mg | PHARMACARE PREMIUM LTD. - MALTA | — | not reimbursed | PR |
| DASATINIB SANDOZ 100 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PRF |
| DASATINIB SANDOZ 100 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PRF |
| DASATINIB SANDOZ 100 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PRF |
| DASATINIB SANDOZ 20 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PRF |
| DASATINIB SANDOZ 20 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PRF |
| DASATINIB SANDOZ 20 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PRF |
| DASATINIB SANDOZ 20 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PRF |
| DASATINIB SANDOZ 20 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PRF |
| DASATINIB SANDOZ 50 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PRF |
| DASATINIB SANDOZ 50 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PRF |
| DASATINIB SANDOZ 50 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PRF |
| DASATINIB SANDOZ 50 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PRF |
| DASATINIB SANDOZ 70 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PRF |
| DASATINIB SANDOZ 70 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PRF |
| DASATINIB SANDOZ 70 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PRF |
| DASATINIB SANDOZ 70 mg | REMEDICA LTD. - CIPRU | — | not reimbursed | PRF |
| DASATINIB STADA 100 mg | REMEDICA LIMITED - CIPRU | — | not reimbursed | PR |
| DASATINIB STADA 100 mg | REMEDICA LIMITED - CIPRU | — | not reimbursed | PR |
| DASATINIB STADA 100 mg | REMEDICA LIMITED - CIPRU | — | not reimbursed | PR |
| DASATINIB STADA 20 mg | REMEDICA LIMITED - CIPRU | — | not reimbursed | PR |
| DASATINIB STADA 20 mg | REMEDICA LIMITED - CIPRU | — | not reimbursed | PR |
| DASATINIB STADA 20 mg | REMEDICA LIMITED - CIPRU | — | not reimbursed | PR |
| DASATINIB STADA 20 mg | REMEDICA LIMITED - CIPRU | — | not reimbursed | PR |
| DASATINIB STADA 20 mg | REMEDICA LIMITED - CIPRU | — | not reimbursed | PR |
| DASATINIB STADA 50 mg | REMEDICA LIMITED - CIPRU | — | not reimbursed | PR |
| DASATINIB STADA 50 mg | REMEDICA LIMITED - CIPRU | — | not reimbursed | PR |
| DASATINIB SUN 100 mg | SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. - TARILE DE JOS | — | not reimbursed | PR |
| DASATINIB SUN 140 mg | SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. - TARILE DE JOS | — | not reimbursed | PR |
| DASATINIB SUN 80 mg | SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. - TARILE DE JOS | — | not reimbursed | PR |
| DASATINIB TEVA 100 mg | MERCKLE GMBH - GERMANIA | — | not reimbursed | PR |
| DASATINIB TEVA 100 mg | MERCKLE GMBH - GERMANIA | — | not reimbursed | PR |
| DASATINIB TEVA 20 mg | MERCKLE GMBH - GERMANIA | — | not reimbursed | PR |
| DASATINIB TEVA 20 mg | MERCKLE GMBH - GERMANIA | — | not reimbursed | PR |
| DASATINIB TEVA 20 mg | MERCKLE GMBH - GERMANIA | — | not reimbursed | PR |
| DASATINIB TEVA 20 mg | MERCKLE GMBH - GERMANIA | — | not reimbursed | PR |
| DASATINIB TEVA 50 mg | MERCKLE GMBH - GERMANIA | — | not reimbursed | PR |
| DASATINIB TEVA 50 mg | MERCKLE GMBH - GERMANIA | — | not reimbursed | PR |
| DASATINIB TEVA 50 mg | MERCKLE GMBH - GERMANIA | — | not reimbursed | PR |
| DASATINIB TEVA 50 mg | MERCKLE GMBH - GERMANIA | — | not reimbursed | PR |
| DASATINIB TEVA 70 mg | MERCKLE GMBH - GERMANIA | — | not reimbursed | PR |
| DASATINIB TEVA 70 mg | MERCKLE GMBH - GERMANIA | — | not reimbursed | PR |
| DASATINIB TEVA 70 mg | MERCKLE GMBH - GERMANIA | — | not reimbursed | PR |
| DASATINIB TEVA 70 mg | MERCKLE GMBH - GERMANIA | — | not reimbursed | PR |
| NODRIGA 100 mg | ALKALOID-INT D.O.O. - SLOVENIA | — | not reimbursed | PR |
| NODRIGA 140 mg | ALKALOID-INT D.O.O. - SLOVENIA | — | not reimbursed | PR |
| NODRIGA 20 mg | ALKALOID-INT D.O.O. - SLOVENIA | — | not reimbursed | PR |
| NODRIGA 50 mg | ALKALOID-INT D.O.O. - SLOVENIA | — | not reimbursed | PR |
| NODRIGA 70 mg | ALKALOID-INT D.O.O. - SLOVENIA | — | not reimbursed | PR |
Reimbursement and amounts come from the CNAS nomenclature (SIUI) valid in the current month, for each pack. *What you pay is indicative: the maximum price minus what CNAS pays on the main sublist, for an insured adult. The pharmacy may sell below the maximum price; low-income pensioners, children, pupils and pregnant women may pay less. C1 applies only to the diseases on the list, and C2 within the national programmes.
Prescription status key:
- PR — With a medical prescription (PR)
- PRF — With a medical prescription kept by the pharmacy (P-RF)
Live pharmacy prices
Products with Dasatinib in our comparator
Shelf prices collected from the large chains — see on each product page where it is cheapest.
Good to know
How to read the maximum price
The CANAMED maximum retail price is the legal cap approved by the Ministry of Health — the pharmacy may sell for less, never for more. If the medicine is reimbursed, the sublist percentage (A 90%, B 50%, C1/C2 100%, D 20%) applies to the reference price of the therapeutic group, usually calculated from the cheapest product with the same INN — which is why your contribution can differ from one brand to another, even for the same active substance. The electronic prescription automatically shows the exact amount to pay; for non-prescription shelf prices, use the HartaFarmacii comparator.
CANAMED catalogue
Other active substances in the catalogue
- Dabigatran etexilat
- Dapagliflozin
- Diclofenac
- Duloxetin
- Desloratadin
- Donepezil
- Dexamethason
- Dimethyl fumarate
- Diverse
- Deferasirox
See also the full list of reimbursed medicines, with an alphabetical index of all active substances.
Frequently asked questions
FAQ · Dasatinib
-
Is Dasatinib reimbursed?
Yes. For 38 of the catalogue entries with Dasatinib we have the reimbursement percentage on record. The percentage depends on the CNAS sublist each product is placed on (A 90%, B 50%, C1/C2 100%, D 20%) and applies to the reference price of the therapeutic group, not to the shelf price. Ask the doctor or pharmacist for the exact placement. -
What is the CANAMED maximum price for Dasatinib?
The maximum retail prices (the CANAMED legal cap) for medicines with Dasatinib are between 4167.93 and 18736.42 RON. No pharmacy may sell above the maximum price, but it may sell below it — compare real prices with the HartaFarmacii comparator. -
What percentage of Dasatinib is reimbursed?
The percentage depends on the CNAS sublist: A 90% (common chronic diseases), B 50% (partial reimbursement), C1 and C2 100% (serious chronic diseases and national programmes), D 20%. The percentage applies to the reference price set by CNAS, not to the shelf price, so you may pay a difference even for a “100% reimbursed” medicine. You can see the exact placement on the electronic prescription. -
How many medicines with Dasatinib are in the CANAMED catalogue?
The CANAMED catalogue holds 113 authorised medicines with the active substance Dasatinib — different brand names, strengths and pharmaceutical forms. You will find them all, with maximum price and prescription status, in the table on this page. Latest CANAMED import into the HartaFarmacii database: 2026-11-03.
Before you go